Tremor induction by intracaudate injections of bretylium, tetrabenazine, or mescaline: functional deficits in caudate dopamine.
D000109:Acetylcholine / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001949:Bretylium Compounds / Q000037:antagonists & inhibitors; D002415:Cats; D002421:Caudate Nucleus / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism* / Q000494:pharmacology; D004567:Electrodes, Implanted; D004837:Epinephrine / Q000494:pharmacology; D006426:Hemicholinium 3 / Q000494:pharmacology; D008297:Male; D008635:Mescaline / Q000037:antagonists & inhibitors; D008845:Microinjections; D012601:Scopolamine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013238:Stereotaxic Techniques; D013747:Tetrabenazine / Q000037:antagonists & inhibitors; D013997:Time Factors; D014202:Tremor / Q000139:chemically induced* / Q000378:metabolism
D001949:Bretylium Compounds; D006426:Hemicholinium 3; D012701:Serotonin; D012601:Scopolamine; D000109:Acetylcholine; D008635:Mescaline; D004298:Dopamine; D004837:Epinephrine; D013747:Tetrabenazine